Mice infected with M. tuberculosis with Rv0678 mutations still benefit from bedaquiline treatment
Saved in:
Main Authors: | N. Lounis, T. Gevers, C. Villellas, K. Andries |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2024-11-01
|
Series: | IJTLD Open |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000011/art00009 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative growth kinetics and drug susceptibility of Mycobacterium tuberculosis lineages prevalent in Ethiopia: implications for tuberculosis treatment and management
by: Tesfaye Gebreyohannis Hailemariam, et al.
Published: (2025-02-01) -
Retrospective Analysis of Penicillin G Minimum Inhibitory Concentration for Gram-Positive Isolates of Non-Severe Clinical Mastitis
by: Stefanie Leimbach, et al.
Published: (2025-01-01) -
The first assessment of antimicrobial sensitivity of Mycoplasma gallisepticum and M. synoviae from laying hens in Brazil
by: D.S. Fialho, et al.
Published: (2025-01-01) -
Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
by: Denise Rossato Silva, et al.
Published: (2025-01-01) -
Cartridge-based sequencing for bedaquiline resistance detection from sputum
by: J.D. Limberis, et al.
Published: (2024-09-01)